CELESTONE SOLUSPAN is a Intra-articular; Intralesional; Intramuscular; Soft Tissue Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Betamethasone Acetate; Betamethasone Sodium Phosphate.
Product ID | 0085-4320_21506ad3-4b4e-4052-b848-8620c428fcbc |
NDC | 0085-4320 |
Product Type | Human Prescription Drug |
Proprietary Name | CELESTONE SOLUSPAN |
Generic Name | Betamethasone Acetate And Betamethasone Sodium Phosphate |
Dosage Form | Injection, Suspension |
Route of Administration | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
Marketing Start Date | 2017-03-02 |
Marketing Category | NDA / NDA |
Application Number | NDA014602 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
Active Ingredient Strength | 3 mg/mL; mg/mL |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |